Pathstone Family Office’s Exponent EXPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$339K Buy
3,961
+1,374
+53% +$124K ﹤0.01% 1241
2023
Q2
$253K Sell
2,587
-504
-16% -$47.4K ﹤0.01% 1041
2023
Q1
$322K Sell
3,091
-7,633
-71% -$777K 0.01% 881
2022
Q4
$750K Buy
10,724
+6,031
+129% +$586K 0.01% 916
2022
Q3
$411K Buy
+4,693
New +$445K ﹤0.01% 1150
2021
Q1
Sell
-6
Closed 887
2020
Q4
$0 Hold
6
﹤0.01% 1199
2020
Q3
$0 Sell
6
-6
-50% -$477 ﹤0.01% 862
2020
Q2
$0 Buy
+12
New +$864 ﹤0.01% 800

Other funds holding EXPO

Pathstone Family Office's EXPO Position: Q3 2023 in Review

Pathstone Family Office increased its Exponent (EXPO) stake by 53% in Q3 2023, buying an estimated $124K and bringing the position to 3,961 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #1241.

Pathstone Family Office first reported a position in EXPO in Q2 2020 and has held it in 8 quarters since. The position peaked at $750K in Q4 2022. 356 funds tracked by Wall St. Rank hold EXPO as of Q3 2023.

  • Pathstone Family Office held 3,961 shares of Exponent worth $339K as of Q3 2023.
  • Pathstone Family Office bought 1,374 Exponent shares in Q3 2023, an estimated $124K.
  • Exponent made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1241 holding.
  • Pathstone Family Office first reported a position in Exponent in Q2 2020 and has held it in 8 quarters since.
  • Pathstone Family Office's Exponent position peaked at $750K in Q4 2022.
  • 356 funds tracked by Wall St. Rank held Exponent as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.